Skip to main content
News

Leukemia vaccine passes key trial, adding to breakthrough year for cancer drugs

Leukemia vaccine passes key trial, adding to breakthrough year for cancer drugs

Feed excerpt — reported by Washington Post

The vaccine reduced risk of death for certain acute myeloid leukemia patients, according to drugmaker

MAP records observable characteristics of the original article (publisher, author, date, references, framing cues). MAP does not verify the article’s claims or score it. Read the full original story at Washington Post →

Original Source

This article was syndicated from Washington Post. All rights remain with the original publisher.